No treatment or drug gets to market without a clinical trial. Many of those trials don’t just happen in academic settings, ...

Accenture (ACN) closed at $384.84 in the latest trading session, marking a -1.38% move from the prior day. This change lagged the S&P 500's daily loss of 0.43%. Elsewhere, the Dow saw a downswing of 1 ...

Key tools China introduced last year to stabilise the property market are making very little impact, pressuring Beijing to find new solutions for the crisis-hit sector, which analysts say must involve ...

The recommendation change came from Susquehanna Research one day after Lam's research day. Susquehanna now feels Lam is worthy of a positive (i.e., buy) tag; previously, it had flagged the stock as ...

In addition to competitive threats to FUA pricing, Netwealth’s FUA is also exposed to financial market movements. Financial market weakness could trigger issues with investment products which could ...

Growing NEV Adoption: The market for new market vehicles (NEVs) is on the rise in China. NIO expects vehicle deliveries in ...

BioMarin's gene therapy pipeline has had setbacks, including a three-year delay in US approval of Roctavian and stalled development of PKU gene therapy BMN 307 as the Food and Drug Administration ...

Yext stock beats revenue estimates in FQ3 2025, aided by acquisitions like Hearsay Systems. Click here to read an analysis of ...

The company’s shares retreated about 6% in premarket trading Thursday after executives set 2026 fiscal-year revenue and ...

Walmart stock is sinking Thursday as the retail giant's dreary outlook offsets a fourth-quarter earnings beat and dividend ...

We recently published a list of Top 10 AI Stocks Buzzing on Latest News. In this article, we are going to take a look at ...